About Us

Procaps Group, S.A. ("Procaps Group") (NASDAQ: PROC) is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5.000 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

ESG Report 2022

Our Sustainable Way: Driving Innovation, shaping a Healthier Future

View Report
ESG Report

Recent News

March 4, 2024 

Procaps Announces Formation of Strategic Committee to Explore Value Creation AlternativesProcaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--Mar. 4, 2024-- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated Latam healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategic alternatives to maximize

View all news

Pharmaceutical Group dedicated to delivering health and nutrition

Pharmaceutical Group
dedicated to delivering
health and nutrition

We employ over 5.000 people across 13 countries

We employ over 5.000 people across 13 countries
 

Our products reach 50+ markets

Our products reach 
50+ markets